Register entry
Emergent Product Development Gaithersburg Inc.
Data as of · How to read this entry
- Registered sites
- 0
- Active NDC listings
- 5
- Live patents
- 0
- Countries
- 0
Catalogue
Drug listings by form and route
55 active NDC listings: 5 vaccine. By marketing category: BLA 5.
| Dosage form | NDCs |
|---|---|
| injection, powder, lyophilized, for solution | 2 |
| solution | 2 |
| injection, suspension | 1 |
| Route | NDCs |
|---|---|
| percutaneous | 4 |
| intramuscular | 1 |
| Labeller name on the listing | NDCs |
|---|---|
| emergent product development gaithersburg inc. | 5 |
Catalogue
Marketed products
5| Brand | Generic name | Form / route | NDC |
|---|---|---|---|
| ACAM2000 | smallpox and mpox (vaccinia) vaccine, live | injection, powder, lyophilized, for solution, percutaneous | 71665-330BLA |
| ACAM2000 | smallpox and mpox (vaccinia) vaccine, live | injection, powder, lyophilized, for solution, percutaneous | 71665-430BLA |
| CYFENDUS | Anthrax Vaccine Adsorbed, Adjuvanted | injection, suspension, intramuscular | 71665-001BLA |
| Diluent for ACAM2000 | diluent for smallpox and mpox (vaccinia) vaccine, live | solution, percutaneous | 71665-340BLA |
| Diluent for ACAM2000 | diluent for smallpox and mpox (vaccinia) vaccine, live | solution, percutaneous | 71665-440BLA |
Enquiry
Common questions
- Is Emergent Product Development Gaithersburg Inc. FDA approved?
- Emergent Product Development Gaithersburg Inc. holds no registered establishment of its own; 5 drug products are listed under its name in the National Drug Code Directory, made at sites registered to other firms.
- What drugs does Emergent Product Development Gaithersburg Inc. make?
- 5 products are listed under Emergent Product Development Gaithersburg Inc. in the openFDA NDC Directory, most often as injection, powder, lyophilized, for solution; solution; injection, suspension. The full breakdown by dosage form and route is above. A listing count is not a sales figure.
Compiled from FDA establishment registrations, the openFDA NDC Directory, the Orange Book and the FDA drug shortage database. Not claimed by the company. Sources and methodology.